These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24211060)

  • 1. CYP2D6 phenotypes and Parkinson's disease risk: a meta-analysis.
    Lu Y; Peng Q; Zeng Z; Wang J; Deng Y; Xie L; Mo C; Zeng J; Qin X; Li S
    J Neurol Sci; 2014 Jan; 336(1-2):161-8. PubMed ID: 24211060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP2D6*4 allele polymorphism increases the risk of Parkinson's disease: evidence from meta-analysis.
    Lu Y; Mo C; Zeng Z; Chen S; Xie Y; Peng Q; He Y; Deng Y; Wang J; Xie L; Zeng J; Li S; Qin X
    PLoS One; 2013; 8(12):e84413. PubMed ID: 24376807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450 2D6 and Parkinson's Disease: Polymorphism, Metabolic Role, Risk and Protection.
    Ur Rasheed MS; Mishra AK; Singh MP
    Neurochem Res; 2017 Dec; 42(12):3353-3361. PubMed ID: 28871472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinson's disease and CYP2D6 polymorphism in Asian populations: A meta-analysis.
    Persad AS; Stedeford T; Tanaka S; Chen L; Banasik M
    Neuroepidemiology; 2003; 22(6):357-61. PubMed ID: 14557687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinson's disease, CYP2D6 polymorphism, and age.
    Payami H; Lee N; Zareparsi S; Gonzales McNeal M; Camicioli R; Bird TD; Sexton G; Gancher S; Kaye J; Calhoun D; Swanson PD; Nutt J
    Neurology; 2001 May; 56(10):1363-70. PubMed ID: 11376189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between vitamin D receptor gene polymorphisms and susceptibility to Parkinson's disease: a meta-analysis.
    Zhang ZT; He YC; Ma XJ; Li DY; Lu GC
    Neurosci Lett; 2014 Aug; 578():122-7. PubMed ID: 24993298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of polymorphism in cytochrome P450 2D6 and N-acetyltransferase-2 with Parkinson's disease.
    Singh M; Khanna VK; Shukla R; Parmar D
    Dis Markers; 2010; 28(2):87-93. PubMed ID: 20364044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of A313 G polymorphism (GSTP1*B) in the glutathione-S-transferase P1 gene with sporadic Parkinson's disease.
    Vilar R; Coelho H; Rodrigues E; Gama MJ; Rivera I; Taioli E; Lechner MC
    Eur J Neurol; 2007 Feb; 14(2):156-61. PubMed ID: 17250723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between bone marrow stromal cell antigen 1 gene polymorphisms and the susceptibility to Parkinson's disease: a meta-analysis.
    Wang S; Xu YF; Ding XY; Liu ZR; Ding Y; Jin B; Wang S; Ding MP
    Neurosci Lett; 2015 Jul; 599():120-4. PubMed ID: 25986899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between polymorphisms in the cytochrome P-450 2D6 gene and Parkinson's disease: a case-control study and meta-analysis.
    McCann SJ; Pond SM; James KM; Le Couteur DG
    J Neurol Sci; 1997 Dec; 153(1):50-3. PubMed ID: 9455978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic analysis of the CYP2D6 gene in patients with Parkinson's disease.
    Tsuneoka Y; Matsuo Y; Ichikawa Y; Watanabe Y
    Metabolism; 1998 Jan; 47(1):94-6. PubMed ID: 9440484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of effect of seven functional mutations in the CYP2D6 gene in Parkinson's disease.
    Joost O; Taylor CA; Thomas CA; Cupples LA; Saint-Hilaire MH; Feldman RG; Baldwin CT; Myers RH
    Mov Disord; 1999 Jul; 14(4):590-5. PubMed ID: 10435495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene-gene and gene-environment interaction on the risk of Parkinson's disease.
    Singh NK; Banerjee BD; Bala K; Chhillar M; Chhillar N
    Curr Aging Sci; 2014; 7(2):101-9. PubMed ID: 25101650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP2D6 polymorphism and Parkinson's disease susceptibility.
    Sabbagh N; Brice A; Marez D; Dürr A; Legrand M; Lo Guidice JM; Destée A; Agid Y; Broly F
    Mov Disord; 1999 Mar; 14(2):230-6. PubMed ID: 10091614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP2D6 polymorphism in Parkinson's disease: the Rotterdam Study.
    Harhangi BS; Oostra BA; Heutink P; van Duijn CM; Hofman A; Breteler MM
    Mov Disord; 2001 Mar; 16(2):290-3. PubMed ID: 11295783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotyping of CYP2D6 in Parkinson's disease.
    Stefanović M; Topić E; Ivanisević AM; Relja M; Korsić M
    Clin Chem Lab Med; 2000 Sep; 38(9):929-34. PubMed ID: 11097352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between Functional CYP2D6 Polymorphisms and Susceptibility to Autoimmune Diseases: A Meta-Analysis.
    Lee YH; Bae SC
    Immunol Invest; 2017 Feb; 46(2):109-122. PubMed ID: 27749127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MTHFR C677T and A1298C polymorphisms may contribute to the risk of Parkinson's disease: A meta-analysis of 19 studies.
    Liu L; Zhang L; Guo L; Yu Q; Li H; Teng J; Xie A
    Neurosci Lett; 2018 Jan; 662():339-345. PubMed ID: 29097250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative assessment of CYP2D6 polymorphisms and risk of Alzheimer's disease: a meta-analysis.
    Lu Y; Qin X; Li S; Zhang X; He Y; Peng Q; Deng Y; Wang J; Xie L; Li T; Zeng Z
    J Neurol Sci; 2014 Aug; 343(1-2):15-22. PubMed ID: 24909950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP2D6 allelic frequencies in young-onset Parkinson's disease.
    Sandy MS; Armstrong M; Tanner CM; Daly AK; Di Monte DA; Langston JW; Idle JR
    Neurology; 1996 Jul; 47(1):225-30. PubMed ID: 8710083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.